Dr. Annette Kim recognized as CAP Laboratory Improvement Programs Service Award Winner
By Anastazia Hartman | September 25
At this year’s annual meeting of the College of American Pathologists (CAP), Annette S. Kim, MD, PhD, FCAP, received the prestigious 2025 CAP Laboratory Improvement Programs Service Award in recognition of her transformative leadership as the vice-chair of the Personalized Health Care Committee (PHC). She shares this honor with her longtime collaborator, Dr. Jordan S. Laser, MD, FCAP, who serves as the chair of the PHC. In January 2026, Dr. Kim will serve as chair of the committee.
Dr. Kim, the Henry Clay Bryant Professor of Pathology and Director of the Division of Diagnostic Genetics and Genomics at the University of Michigan, Michigan Medicine, has played a central role in advancing CAP’s personalized health care initiatives. Her leadership has not only propelled precision medicine forward but also laid the groundwork for improved patient care across pathology and oncology.
“I am incredibly honored to receive this award,” Dr. Kim said. “This award is not just an award for me and Dr. Laser, but also a true testament to the hard work of the entire committee. Over the past many years, our committee has been dedicated to creating new projects and avenues that benefit the pathology community and, most importantly, our patients.”
Under Dr. Kim’s guidance, the PHC has become a pioneering force within CAP. Together with Dr. Laser, Dr. Kim has overseen several groundbreaking initiatives. These include:
-
CAP Biomarker OneSource: a comprehensive, web-based educational platform that centralizes biomarker information and supports consistency in clinical use.
-
Harmonization Projects: a strategic, three-phase effort to address the lack of standardization in biomarker testing, improving reliability and diagnostic accuracy for patients worldwide.
Dr. Kim’s vision has also supported cross-disciplinary collaborations, ensuring that the PHC’s work benefits not just pathologists but also oncologists, researchers, and the patients whose treatment depends on precision diagnostics. Through her leadership, Dr. Kim has reinforced pathology’s central role in personalized medicine, demonstrating how innovation, collaboration, and foresight can reshape the future of health care.
ON THE COVER
ON THE COVER
ON THE COVER
ON THE COVER
ON THE COVER
ON THE COVER
ON THE COVER
ON THE COVER
ON THE COVER
ON THE COVER
ON THE COVER
